CLOSE X

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE3542.7039.35 (+1.12 %)
PREV CLOSE ( ) 3503.35
OPEN PRICE ( ) 3503.05
BID PRICE (QTY) 3538.20 (3)
OFFER PRICE (QTY) 3543.95 (4)
VOLUME 2590
TODAY'S LOW / HIGH ( )3490.00 3551.00
52 WK LOW / HIGH ( )2335 3598.4
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta Tower, 54 - A,M V Road, Chakala,Andheri (East),
Mumbai,
Maharashtra-400093

Phone 022-60609000 / 66061000

Email legal.info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
20Jul Ajanta Pharma informs about board mee
With reference to its letter dated 20th July 2026, informing about the B..
20Jul Ajanta Pharma informs about conferenc
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
14Jul Ajanta Pharma informs about substantia
Ajanta Pharma has informed that it enclosed Disclosure under Regulation..
07Jul Ajanta Pharma informs about certificate
Ajanta Pharma has informed that it enclosed a certificate under Regulati..
03Jul Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that the exchange has received Disclosure und..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit3154.79468.2
Gross Profit 4234.5 12310.3
Operating Profit 4675.214023.9
Net Sales 14886.748459.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28146.90 (0.49%)
M.Cap ( in Cr)59810.20
Pfizer (BSE)
 5020.05 (2.46%)
M.Cap ( in Cr)22965.59
Fredun Pharma (BSE)
 1393.70 (9.22%)
M.Cap ( in Cr)2304.91
Venus Remedies (BSE)
 1657.00 (5.00%)
M.Cap ( in Cr)2214.91
Haleos Labs (BSE)
 1490.30 (5.11%)
M.Cap ( in Cr)450.56
Shareholding Pattern
PROMOTERS 63.48%
MUTUAL FUNDS/UTI 18.1%
NON-INSTITUTION 7.03%
FI/BANKS/INSURANCE 3.29%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data July 2026 Broking Complaints Data July 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.